Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection

  • Authors:
    • Wei Juan Cai
    • Liang Yin
    • Di Zhou
    • Wen Jiang Cao
    • Wei Wei Zheng
    • Lei Sheng
    • Jiang Cheng
  • View Affiliations

  • Published online on: August 16, 2012     https://doi.org/10.3892/mmr.2012.1035
  • Pages: 1069-1074
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to investigate the relationship between E-selectin +G98T, +A561C polymorphisms and the levels of hepatitis B virus (HBV) DNA and preS1 antigen (preS1Ag) in patients with chronic hepatitis B (CHB) infection. Polymorphisms of the E-selectin gene in 150 CHB patients and 150 healthy controls of two different nationalities were detected using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Real-time quantitative PCR was used to detect the levels of HBV DNA. preS1Ag and five items of hepatitis B were detected by enzyme-linked immunosorbent assay. Two genotypes, GG (94%, 96%) and GT (6%, 4%) of the E-selectin +G98T polymorphism, and AA (78.67%, 80.67%) and AC (21.33%, 19.33%) of the +A561C polymorphism, were found in these patients. There were also significant differences in the two nationalities in the genotypic frequencies in +A561C polymorphisms between patients and healthy subjects (χ2=5.489, χ2=5.653; P<0.05). In the patients studied, the relative risk of suffering from CHB in genotype AC was 2.122 and 2.313-fold higher for the two nationalities, respectively, than that of the AA genotype (OR=2.122, 95% CI 1.121-4.019; OR=2.313, 95% CI 1.002-5.360). There was also significant over-representation in the C allele frequency between the two groups (χ2=5.000, χ2=5.30; P<0.05), and the levels of HBV DNA and preS1Ag in the AC genotype patients were higher than those in the AA genotype (P<0.01 and P<0.05). E-selectin +A561C and +G98T polymorphisms were present in the populations studied. Therefore, there is a correlation between E-selectin +A561C polymorphisms and CHB. Allele C may be one of the predisposing factors, and mutation of this locus may impact the virus copy number.

Introduction

Chronic hepatitis B (CHB) is a chronic infectious disease induced by a complex interaction between polygenes and multiple factors. A previous study showed that this variability of the disease was partially attributed to the host immunological and genetic factors (1). Evidence has shown that the gene polymorphisms of certain cytokines, such as tumor necrosis factor and interleukin, are involved in the occurrence and development of CHB. Ben-Ari et al showed that there is a correlation between the occurrence and development of CHB with cytokines and the network regulation of cytokines (2).

E-selectin, known as human leukocyte differentiation antigen CD62E, belongs to the selectin family of adhesion molecules. As the body of a pro-inflammatory cytokine, it is involved in many white cell and CD4+ memory T-cell subsets in adhesion and aggregation, and plays a pivotal role in the process of immune and inflammatory responses (3). In a previous study, as a result of HBV long-term stimulation and circulation of lymphocyte and macrophage activation, a variety of inflammatory cytokines was released which induced the increase of E-selectin gene transcription and stimulated liver endothelial cells to express and release E-selectin (2).

The G98 to T transversion in the E-selectin gene occurs in the untranslated region of exon 2, and the A561 to C transversion occurs in the epidermal growth factor-like domain of exon 4; these were previously reported to be associated with atherosclerosis in a German population (4). Few studies have been carried out on the association between the E-selectin gene polymorphisms and CHB. Yan et al(5) studied a Han population of Shandong in 2006 and demonstrated that the serum levels of E-selectin had an impact on the occurrence and development of CHB. In 2007, Hajilooi et al(6) studied a population of Iran and found that the E-selectin gene polymorphisms of Ser128Arg and Leu554Phe were not considered a risk factor for CHB infection. In 2009, a study of a Hubei Han population showed that the E-selectin +A561C polymorphisms may be associated with liver cirrhosis in patients with chronic hepatitis B virus (HBV) infection, and the +G98T polymorphism may be associated with fibrotic severity (7).

Data from China and other countries have shown that E-selectin gene polymorphisms and allele frequencies are present in different races and nations (8,9). Luo et al examined different ethnic groups in China that suffered from HBV infection. Their results showed the following percentages for positive HbsAg: Han, 15.3%; Tibetan, 26.2%; Yao, 24.0%; Li, 7.0% and Uygur, 5.3%. Different rates of HBV infection were observed among these ethnic groups (10). In Xinjiang, a typical multiracial province, minority populations are higher, thereby providing a valuable heredity resource. E-selectin is known to affect the occurrence and development of CHB, however, no study has focused on the E-selectin gene polymorphisms in Han and Uygur populations with liver diseases. Therefore, the aim of the present study was to investigate the association of E-selectin polymorphisms with disease progression in chronic HBV-infected patients and to determine the HBV DNA copies and levels of preS1 antigen (preS1Ag) in the circulation of individuals in Chinese Han and Uygur populations. Additionally, we investigated diagnostic factors in Xinjiang Han and Uygur CHB patients to determine susceptibility and prognosis in order to provide guidance for the management and treatment of CHB.

Materials and methods

Study subjects

From January to July 2010, 150 patients with CHB infection (mean age, 37.6±10.7 years) and 150 control subjects (mean age, 34.5±11.2 years) were recruited sequentially from the Chinese Han populations in Xinjiang Shihezi. From July to September 2010, a further 150 patients (mean age 39.6±9.7 years) and 150 control subjects (mean age 34.5±11.2 years) were recruited sequentially from the Uygur population in Xinjiang Akesu. Patients were diagnosed according to the ‘Guideline on Prevention and Treatment of Chronic Hepatitis B’ by the Chinese Society of Hepatology (11). None of the patients had any other types of liver diseases, such as chronic hepatitis C, alcoholic liver diseases, autoimmune liver diseases or metabolic liver diseases. None of the control subjects suffered from liver, kidney, incretion, cardiovascular or cerebrovascular diseases. The study was carried out with the approval of the local hospital's ethics committee. All participants gave their informed consent to participate.

Genomic DNA

DNA was extracted from blood samples of the study subjects using a blood genome DNA extraction kit (GeneCore BioTeke Co., Ltd., Beijing, China). The primers, designed as previously described (12), are shown in Table I. The primers were synthesized and purified by the Shanghai Sangon Biological Engineering Technology and Services Co., Ltd. (Shanghai, China).

Table I

Amplified fragment sequences.

Table I

Amplified fragment sequences.

Gene locusAmplified product size (bp)
+G98T332
 F: 5′-TGCCCAAAATCTTAGGATGC-3′
 R: 5′-AAGCCCAGGGAAGAACACAT-3′
+A561C357
 F: 5′-ATGGCACTCTGTAGGACTGCT-3′
 R: 5′-GTCTCAGCTCACGATCACCAT-3′

[i] F, forward; R, reverse.

Polymerase chain reaction (PCR) amplification of the +G98T and +A561C polymorphisms

PCR was performed in a total volume of 25 μl containing 3.0 μl DNA, 0.5 μl of each primer, 12.5 μl PCR mix (including dNTPs and MgCl2; Shanghai Sangon Biological Engineering Technology and Services Co., Ltd.) and 8.5 μl distilled water. Amplification was carried out using the British TC-512 gradient automatic PCR amplification instrument (negative controls without DNA template). The reaction was performed as follows: an initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturing at 94°C for 30 sec, annealing at 59°C for 30 sec, with extension for 45 sec at 72°C and a final extension at 72°C for 10 min. The +A561C PCR product (357 bp) was then digested by PstI restriction endonuclease (Fermentas, Vilnius, Lithuania). The +G98T PCR product (332 bp) was digested by HPhI restriction endonuclease (Fermentas), and the digested products were run on a 3% agarose gel and visualised under UV light by ethidium bromide staining.

Laboratory determination

For HBV DNA copies, PE7300 real-time fluorescent quantitative PCR analyzer (DAAN Gene Co. Ltd. of Sun Yat-sen University, Shenzhen, China) was used. Experimental clinical trusted sensitivity was 1×103 copies/ml. For plasma preS1Ag and five items of hepatitis B, the ELISA kit was used. The critical value of preS1Ag was average absorbance of negative controls multiplied by 2.5.

Statistical analysis

Statistical analysis was performed using the SPSS software version 16.0 (SPSS Inc., Chicago, IL, USA). Each result was calculated as the mean ± SD. The Hardy-Weinberg balance was used to check the sample with group representation. Differences in genotypic and allelic frequency between ethnic groups were evaluated using the Fisher's exact test or the χ2 test as appropriate, involving HBV DNA variables after log transformation analysis. The odds ratio (OR) was calculated together with its 95% confidence interval (CI). P<0.05 was considered to indicate statistically significant differences.

Results

E-selectin polymorphism detection

The E-selectin +G98T gene polymorphism is shown in Fig. 1. The PCR amplified fragment was 332 bp. By restriction mapping, we found that this transversion abolished the recognition site for HphI. There were two types of genotypes: homozygous wild-type GG (194 and 138 bp), and heterozygous genotype GT (332, 194 and 138 bp). Sequencing results are shown in Fig. 3A and B.

The E-selectin +A561C PCR amplified fragment was 357 bp. Using restriction endonuclease PstI, two genotypes were evident: homozygous wild-type AA (219 and 138 bp) and heterozygous genotype GT (357, 219 and 138 bp) (Fig. 2). Sequencing results are shown in Fig. 3C and D.

Discussion

Using the Hardy-Weinberg balance test, the E-selectin +G98T and +A561C genotypes were shown to achieve a genetic balance in the Han and Uygur populations with regard to the distribution frequency, which had a group representation. Results of the χ2 test and correlation analysis showed that E-selectin +A561C and +G98T polymorphisms were present in the Xinjiang Han and Uygur populations. Significant differences were found in the allele and genotype frequencies of the +A561C polymorphism between patients and controls in the Han and Uygur populations (P<0.05). In the Han population, the relative risk of suffering from CHB in the AC genotype was 2.122-fold higher than that of the AA genotype (OR=2.122, 95% CI 1.121–4.019). Results of the C allele relative risk analysis were OR=1.988 and 95% CI 1.079–3.666. In the Uygur population, the relative risk for CHB for the AC genotype was 2.313-fold higher than that of the AA genotype (OR=2.313, 95% CI 1.002–5.360). Findings of the C allele relative risk analysis were OR=2.183 and 95% CI 1.104–4.318. These results suggest that the changes observed for the E-selectin +A561C gene polymorphisms are one of the genetic factors of CHB, thus the C allele may be a risk factor (Table III).

Table III

Comparison of the E-selectin +A561C genotypes and alleles in patients and controls [n (%)].

Table III

Comparison of the E-selectin +A561C genotypes and alleles in patients and controls [n (%)].

GroupsNo.GenotypeAllele


AAACAC
Han
 Cases150118 (78.67)32 (21.33)268 (89.33)32 (10.67)
 Controls150133 (88.67)17 (11.33)283 (94.33)17 (5.67)
 χ2 value5.4895.000
 P-value<0.025<0.050
 OR (95% CI)2.122 (1.121–4.019)1.988 (1.079–3.666)
Uygur
 Cases150123 (82.00)27 (18.00)273 (91.00)27 (9.00)
 Controls150137 (91.30)13 (8.70)287 (95.70)13 (4.30)
 χ2 value5.6535.300
 P-value<0.025<0.025
 OR (95% CI)2.313 (1.002–5.360)2.183 (1.104–4.318)

Investigations into the gene polymorphisms of CHB and HBV DNA copies and the levels of preS1Ag found that these polymorphisms were significantly higher in AC genotype patients than in AA genotype patients (P<0.01, P<0.05). By means of logistic regression analysis and using the AA and AC genotypes as variables, a correlation was found between the AC genotype and the HBV DNA copies and levels of preS1Ag (P<0.01). E-selectin may be an endothelial cell injury marker of patients with CHB. A significant increase of HBV DNA and S1 antigen in the AC genotype may induce the release of more inflammatory factors and stimulate the immune system to generate a strong response, leading to activation of the HBV replication in vivo of the AC genotype (Table IV).

Table IV

Comparison of the +A561C genotypes and HBV DNA copies (Log10 copies/ml) and the levels of preS1Ag [n (%)] in the Han and Uygur patients with chronic hepatitis B.

Table IV

Comparison of the +A561C genotypes and HBV DNA copies (Log10 copies/ml) and the levels of preS1Ag [n (%)] in the Han and Uygur patients with chronic hepatitis B.

GenotypeHanUygur


No.HBV DNApreS1Ag-positiveNo.HBV DNA preS1Ag-positive
AA1181.91±1.5824 (20.33)1232.01±1.3427 (21.95)
AC326.35±2.4617 (53.13)274.79±2.3112 (44.44)
Statistical valuet=12.31 χ2=13.62t=8.413 χ2=5.822
P-value<0.01<0.01<0.01<0.025

[i] HBV DNA variables using log transformation.

No correlation was found between the E-selectin +G98T gene polymorphism and alleles in the Xinjiang Han and Uygur patients. Thus, the T allele is probably not a predisposing factor (Table II). Analysis of the single-nucleotide polymorphism using factors such as sample selection, sample size and ethnic background showed that a larger cohort of samples and the application of different race case-control studies are required to better understand the pathogenesis of CHB.

Table II

Comparison of the E-selectin +G98T genotypes and alleles in patients and controls [n (%)].

Table II

Comparison of the E-selectin +G98T genotypes and alleles in patients and controls [n (%)].

GroupsNo.GenotypeAllele


GGGTGT
Han
 Cases150141 (94.0)9 (6.0)291 (97.0)9 (3.0)
 Controls150138 (92.0)12 (8.0)288 (96.0)12 (4.0)
 χ2 value0.5120.444
 P-value>0.050>0.050
 OR (95% CI)0.734 (0.300–1.798)0.743 (0.308–1.790)
Uygur
 Cases150140 (93.3)10 (6.7)290 (96.7)10 (3.3)
 Controls150137 (91.3)13 (8.7)287 (95.7)13 (4.3)
 χ2 value0.4230.407
 P-value>0.050>0.050
 OR (95% CI)0.753 (0.319–1.775)0.761 (0.328–1.763)

In addition, this study compared the E-selectin +G98T polymorphisms and allele frequencies in populations of various countries and nationalities. Table V shows that the +G98T genotype and allele frequencies of the Xinjiang Han population were significantly different from the American (13), German (4), Italian (14) and Gansu Hui populations of China (15) (P<0.05). By contrast, in the China Guangxi Zhuang (9), Guangzhou Han (9) and Uygur of Xinjiang populations, the differences were not statistically significant (P>0.05). A comparison of the E-selectin +A561C polymorphism in populations of various countries and nationalities was performed (Table VI). A comparison of the British (16), American (17), Turkish (18), Iranian (6) and Italian (14) populations showed the differences to be statistically significant (P<0.05). However, a comparison of German (19), Japanese (20), Guangxi Zhuang (9), Guangzhou Han (9) and Uygur of Xinjiang populations showed no statistically significant differences (P<0.05). Therefore, we conclude that E-selectin gene polymorphisms and allele frequencies exist in different races and nationalities, and this difference may affect certain E-selectin gene polymorphism-related diseases.

Table V

E-selectin +G98T polymorphism in populations of different countries and nationalities.

Table V

E-selectin +G98T polymorphism in populations of different countries and nationalities.

Countries/nationalitiesNo.GenotypeAlleleχ2 valueP-value


GGGTTTGT
USA5040 (80.0)10 (20.0)0 (0.0)90 (90.0)10 (10.0)6.9980<0.05
Germany7157 (80.3)14 (19.7)0 (0.0)128 (90.1)14 (10.9)9.7260<0.05
Italy300220 (73.3)77 (25.7)3 (1.0)517 (86.2)83 (13.8)27.060<0.05
China Gansu Hui5041 (82.0)9 (18.0)0 (0.0)91 (91.0)9 (9.0)5.2090<0.05
China Guangxi Zhuang162145 (89.5)16 (9.9)1 (0.6)306 (94.4)18 (5.6)2.5880>0.05
China Guangzhou Han170154 (90.6)16 (9.4)0 (0.0)324 (95.3)16 (4.7)1.2879>0.05
China Xinjiang Uygur150139 (92.7)11 (7.3)0 (0.0)289 (96.3)11 (3.7)0.2140>0.05
China Xinjiang Han150141 (94.0)9 (6.0)0 (0.0)291 (97.0)9 (3.0)

Table VI

E-selectin +A561C polymorphism in populations of various countries and nationalities.

Table VI

E-selectin +A561C polymorphism in populations of various countries and nationalities.

Countries/nationalitiesNo.GenotypeAlleleχ2 valueP-value


AAACCCAC
UK5745 (78.9)11 (19.3)1 (1.8)101 (88.6)13 (11.4)5.022<0.05
USA608427 (70.2)175 (28.8)6 (1.0)1,029 (84.6)187 (15.4)19.490<0.05
Germany10387 (84.5)14 (13.6)2 (1.9)188 (91.3)18 (8.7)3.290>0.05
Turkey9675 (78.1)20 (20.8)1 (1.1)170 (88.5)22 (11.5)5.844<0.05
Japan301276 (91.7)25 (8.3)0 (0.0)577 (95.8)25 (4.2)1.087>0.05
Iran150104 (69.3)40 (26.7)6 (4.0)248 (82.7)52 (17.3)18.830<0.05
Italy300225 (75.0)72 (24.0)3 (1.0)522 (87.0)78 (13.0)11.960<0.05
China Guangxi Zhuang162139 (85.8)20 (12.3)3 (1.9)298 (92.0)26 (8.0)2.910>0.05
China Guangzhou Han170158 (92.9)11 (6.5)1 (0.6)327 (96.2)13 (3.8)3.196>0.05
China Xinjiang Uygur150137 (91.3)13 (8.7)0 (0.0)287 (95.7)13 (4.3)0.593>0.05
China Xinjiang Han150133 (88.7)17 (11.3)0 (0.0)283 (94.3)17 (5.7)

In conclusion, the preliminary results of our study have shown that the E-selectin +A561C and +G98T polymorphisms exist in the Han and Uygur populations and that the +A561C polymorphisms may have an impact on the occurrence, development and levels of HBV replication. However, the exact mechanism of HBV infection in the Xinjiang Han and Uygur populations remains to be determined in future studies.

Acknowledgements

This study was supported by the National Undergraduate Innovative Experiment Program funded projects of Shihezi, China (Grant no. 09107l5925).

References

1 

Thio CL, Thomas DL and Carrington M: Chronic viral hepatitis and the human genome. Hepatology. 31:819–827. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Ben-Ari Z, Mor E, Papo O, et al: Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol. 98:144–150. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301–314. 1994. View Article : Google Scholar : PubMed/NCBI

4 

Wenzel K, Ernst M, Rohde K, et al: DNA polymorphisms in adhesion molecule genes - a new risk factor for early atherosclerosis. Hum Genet. 97:15–20. 1996. View Article : Google Scholar : PubMed/NCBI

5 

Yan MX, Mao HT, Liu Q, et al: Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: correlation with T lymphocyte subsets, NK cells and liver inflammation. Hepatol Res. 35:111–117. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Hajilooi M, Mohammad Alizadeh A, Ranjbar M, et al: E-selectin gene polymorphisms in Iranian chronic hepatitis B patients. Hepat Mon. 7:211–216. 2007.

7 

Wu S, Zhou X, Yang H, et al: Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection. Clin Chem Lab Med. 47:159–164. 2009.PubMed/NCBI

8 

Miller MA, Kerry SM, Dong Y, et al: Circulating soluble E-selectin levels and the Ser128Arg polymorphism in individuals from different ethnic groups. Nutr Metab Cardiovasc Dis. 15:65–70. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Wei YS, Lan Y and Du SK: Distribution of E-selectin gene polymorphism in the Zhuangs and Hans of Guangxi province in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 21:643–645. 2004.(In Chinese).

10 

Luo KX, He C and He HT: Investigation of hepatitis B virus infection in nations of Han, Tibetan, Dai, Yao, Uygur, Mongolian, Li. Zhonghua Liu Xing Bing Xue Za Zhi. 14:266–270. 1993.(In Chinese).

11 

Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl). 120:2159–2173. 2007.PubMed/NCBI

12 

Hamid MA, Amin MA, Kassem HH, et al: E-selection gene polymorphism and coronary artery disease: a genetic association study. Heart Mirror J. 1:55–60. 2007.

13 

Zheng F, Chevalier JA, Zhang LQ, et al: An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clin Genet. 59:58–64. 2001. View Article : Google Scholar : PubMed/NCBI

14 

Fallah M, Bazmani A, Mazloumi Gavgani A, et al: Association between endothelial selectin (E-selectin) gene polymorphisms and E-selectin level with visceral leishmaniasis, in an ARMS-PCR based study. Iran J Parasitol. 3:23–31. 2008.

15 

Ma H, Ma LY, Wang YM, et al: Association of E-selectin gene polymorphisms and coronary heart in Gansu Han, Hui. Zhongguo Lao Nian Za Zhi. 28:1710–1713. 2008.(In Chinese).

16 

Bannan S, Mansfield MW and Grant PJ: Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 41:460–466. 1998. View Article : Google Scholar : PubMed/NCBI

17 

Ellsworth DL, Bielak LF, Turner ST, et al: Gender and age dependent relationships between the E-selectin S128R polymorphisms and coronary heart calcification. J Mol Med. 79:390–398. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Manzoli A, Andreotti F, Varlotta C, et al: Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia. 44:825–830. 1999.PubMed/NCBI

19 

Wenzel K, Blackburn A, Ernst M, et al: Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease. J Mol Med. 75:57–61. 1997. View Article : Google Scholar : PubMed/NCBI

20 

Hattori H, Sato H, Ito D, et al: A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia. Brain Res. 1108:221–223. 2006. View Article : Google Scholar

Related Articles

Journal Cover

November 2012
Volume 6 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cai WJ, Yin L, Zhou D, Cao WJ, Zheng WW, Sheng L and Cheng J: Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection. Mol Med Rep 6: 1069-1074, 2012
APA
Cai, W.J., Yin, L., Zhou, D., Cao, W.J., Zheng, W.W., Sheng, L., & Cheng, J. (2012). Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection. Molecular Medicine Reports, 6, 1069-1074. https://doi.org/10.3892/mmr.2012.1035
MLA
Cai, W. J., Yin, L., Zhou, D., Cao, W. J., Zheng, W. W., Sheng, L., Cheng, J."Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection". Molecular Medicine Reports 6.5 (2012): 1069-1074.
Chicago
Cai, W. J., Yin, L., Zhou, D., Cao, W. J., Zheng, W. W., Sheng, L., Cheng, J."Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection". Molecular Medicine Reports 6, no. 5 (2012): 1069-1074. https://doi.org/10.3892/mmr.2012.1035